Logo image of BRM.CA

BIOREM INC (BRM.CA) Stock Fundamental Analysis

TSX-V:BRM - TSX Venture Exchange - CA09068G1046 - Common Stock - Currency: CAD

2.69  -0.12 (-4.27%)

Fundamental Rating

8

BRM gets a fundamental rating of 8 out of 10. The analysis compared the fundamentals against 24 industry peers in the Commercial Services & Supplies industry. BRM scores excellent points on both the profitability and health parts. This is a solid base for a good stock. BRM has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination! This makes BRM very considerable for value and growth and quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year BRM was profitable.
BRM had a positive operating cash flow in the past year.
BRM had positive earnings in 4 of the past 5 years.
Each year in the past 5 years BRM had a positive operating cash flow.
BRM.CA Yearly Net Income VS EBIT VS OCF VS FCFBRM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1M -1M 2M 3M 4M

1.2 Ratios

With an excellent Return On Assets value of 22.73%, BRM belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
With an excellent Return On Equity value of 55.66%, BRM belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
With an excellent Return On Invested Capital value of 43.30%, BRM belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BRM is significantly above the industry average of 8.06%.
The 3 year average ROIC (25.83%) for BRM is below the current ROIC(43.30%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 22.73%
ROE 55.66%
ROIC 43.3%
ROA(3y)7.87%
ROA(5y)5.15%
ROE(3y)44.72%
ROE(5y)27.7%
ROIC(3y)25.83%
ROIC(5y)N/A
BRM.CA Yearly ROA, ROE, ROICBRM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60 80

1.3 Margins

BRM has a better Profit Margin (11.99%) than 91.67% of its industry peers.
BRM's Profit Margin has declined in the last couple of years.
The Operating Margin of BRM (16.65%) is better than 87.50% of its industry peers.
BRM's Operating Margin has improved in the last couple of years.
BRM has a Gross Margin (31.68%) which is in line with its industry peers.
BRM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 16.65%
PM (TTM) 11.99%
GM 31.68%
OM growth 3Y9.41%
OM growth 5Y11.53%
PM growth 3Y0.35%
PM growth 5Y-14.7%
GM growth 3Y-1.03%
GM growth 5Y1.26%
BRM.CA Yearly Profit, Operating, Gross MarginsBRM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), BRM is creating value.
Compared to 1 year ago, BRM has more shares outstanding
BRM has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, BRM has an improved debt to assets ratio.
BRM.CA Yearly Shares OutstandingBRM.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
BRM.CA Yearly Total Debt VS Total AssetsBRM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

BRM has an Altman-Z score of 5.31. This indicates that BRM is financially healthy and has little risk of bankruptcy at the moment.
BRM has a Altman-Z score of 5.31. This is amongst the best in the industry. BRM outperforms 91.67% of its industry peers.
BRM has a debt to FCF ratio of 0.72. This is a very positive value and a sign of high solvency as it would only need 0.72 years to pay back of all of its debts.
The Debt to FCF ratio of BRM (0.72) is better than 100.00% of its industry peers.
BRM has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.30, BRM is in the better half of the industry, outperforming 79.17% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 0.72
Altman-Z 5.31
ROIC/WACC5.84
WACC7.41%
BRM.CA Yearly LT Debt VS Equity VS FCFBRM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M

2.3 Liquidity

BRM has a Current Ratio of 1.91. This is a normal value and indicates that BRM is financially healthy and should not expect problems in meeting its short term obligations.
BRM has a Current ratio of 1.91. This is in the better half of the industry: BRM outperforms 75.00% of its industry peers.
A Quick Ratio of 1.66 indicates that BRM should not have too much problems paying its short term obligations.
BRM has a Quick ratio of 1.66. This is in the better half of the industry: BRM outperforms 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.91
Quick Ratio 1.66
BRM.CA Yearly Current Assets VS Current LiabilitesBRM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 680.04% over the past year.
BRM shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.05% yearly.
Looking at the last year, BRM shows a very strong growth in Revenue. The Revenue has grown by 93.67%.
BRM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.68% yearly.
EPS 1Y (TTM)680.04%
EPS 3Y38.04%
EPS 5Y3.05%
EPS Q2Q%266.9%
Revenue 1Y (TTM)93.67%
Revenue growth 3Y1.07%
Revenue growth 5Y0.68%
Sales Q2Q%170.19%

3.2 Future

Based on estimates for the next years, BRM will show a very strong growth in Earnings Per Share. The EPS will grow by 29.03% on average per year.
Based on estimates for the next years, BRM will show a very strong growth in Revenue. The Revenue will grow by 23.12% on average per year.
EPS Next Y40.73%
EPS Next 2Y27.65%
EPS Next 3Y29.03%
EPS Next 5YN/A
Revenue Next Year51.03%
Revenue Next 2Y28.43%
Revenue Next 3Y23.12%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BRM.CA Yearly Revenue VS EstimatesBRM.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
BRM.CA Yearly EPS VS EstimatesBRM.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.05 0.1 0.15 0.2 0.25

9

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 8.41, the valuation of BRM can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of BRM indicates a rather cheap valuation: BRM is cheaper than 95.83% of the companies listed in the same industry.
BRM is valuated cheaply when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
BRM is valuated reasonably with a Price/Forward Earnings ratio of 11.87.
Based on the Price/Forward Earnings ratio, BRM is valued a bit cheaper than the industry average as 79.17% of the companies are valued more expensively.
BRM's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.68.
Industry RankSector Rank
PE 8.41
Fwd PE 11.87
BRM.CA Price Earnings VS Forward Price EarningsBRM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BRM indicates a rather cheap valuation: BRM is cheaper than 95.83% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BRM indicates a rather cheap valuation: BRM is cheaper than 83.33% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.39
EV/EBITDA 4.84
BRM.CA Per share dataBRM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

BRM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of BRM may justify a higher PE ratio.
A more expensive valuation may be justified as BRM's earnings are expected to grow with 29.03% in the coming years.
PEG (NY)0.21
PEG (5Y)2.76
EPS Next 2Y27.65%
EPS Next 3Y29.03%

0

5. Dividend

5.1 Amount

No dividends for BRM!.
Industry RankSector Rank
Dividend Yield N/A

BIOREM INC

TSX-V:BRM (2/21/2025, 7:00:00 PM)

2.69

-0.12 (-4.27%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)11-20 2024-11-20
Earnings (Next)04-09 2025-04-09
Inst Owners0.22%
Inst Owner ChangeN/A
Ins Owners1.86%
Ins Owner ChangeN/A
Market Cap43.36M
Analysts84.44
Price Target4.59 (70.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.41
Fwd PE 11.87
P/S 0.94
P/FCF 8.39
P/OCF 8.01
P/B 4.36
P/tB 4.36
EV/EBITDA 4.84
EPS(TTM)0.32
EY11.9%
EPS(NY)0.23
Fwd EY8.42%
FCF(TTM)0.32
FCFY11.92%
OCF(TTM)0.34
OCFY12.48%
SpS2.87
BVpS0.62
TBVpS0.62
PEG (NY)0.21
PEG (5Y)2.76
Profitability
Industry RankSector Rank
ROA 22.73%
ROE 55.66%
ROCE 59.39%
ROIC 43.3%
ROICexc 98.73%
ROICexgc 98.73%
OM 16.65%
PM (TTM) 11.99%
GM 31.68%
FCFM 11.18%
ROA(3y)7.87%
ROA(5y)5.15%
ROE(3y)44.72%
ROE(5y)27.7%
ROIC(3y)25.83%
ROIC(5y)N/A
ROICexc(3y)65.52%
ROICexc(5y)N/A
ROICexgc(3y)65.52%
ROICexgc(5y)N/A
ROCE(3y)35.42%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y2.47%
ROICexc growth 3YN/A
ROICexc growth 5Y2.47%
OM growth 3Y9.41%
OM growth 5Y11.53%
PM growth 3Y0.35%
PM growth 5Y-14.7%
GM growth 3Y-1.03%
GM growth 5Y1.26%
F-Score7
Asset Turnover1.9
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 0.72
Debt/EBITDA 0.37
Cap/Depr 46.44%
Cap/Sales 0.53%
Interest Coverage 250
Cash Conversion 65.81%
Profit Quality 93.26%
Current Ratio 1.91
Quick Ratio 1.66
Altman-Z 5.31
F-Score7
WACC7.41%
ROIC/WACC5.84
Cap/Depr(3y)74.85%
Cap/Depr(5y)77.2%
Cap/Sales(3y)1.07%
Cap/Sales(5y)1.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)680.04%
EPS 3Y38.04%
EPS 5Y3.05%
EPS Q2Q%266.9%
EPS Next Y40.73%
EPS Next 2Y27.65%
EPS Next 3Y29.03%
EPS Next 5YN/A
Revenue 1Y (TTM)93.67%
Revenue growth 3Y1.07%
Revenue growth 5Y0.68%
Sales Q2Q%170.19%
Revenue Next Year51.03%
Revenue Next 2Y28.43%
Revenue Next 3Y23.12%
Revenue Next 5YN/A
EBIT growth 1Y431.43%
EBIT growth 3Y10.58%
EBIT growth 5Y12.29%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y193.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y180.9%
OCF growth 3Y-47.23%
OCF growth 5YN/A